glucose, (beta-d)-isomer has been researched along with Cardiac Hypertrophy in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 14 (87.50) | 24.3611 |
2020's | 2 (12.50) | 2.80 |
Authors | Studies |
---|---|
Cao, D; Chen, X; Li, X; Liu, Q; Luo, Q; Tang, K; Yang, S; Zhong, B | 1 |
Basu, S; Hallow, KM; Yu, H | 1 |
Belló-Klein, A; Bonetto, JHP; Boreham, D; Carraro, CC; da Rosa Araujo, AS; de Lima-Seolin, BG; Fernandes, RO; Khaper, N; Puukila, S; Türck, P | 1 |
Fan, Z; Luo, X; Lv, N; Tan, W | 1 |
Li, J; Ren, J; Tang, QZ; Wan, CX; Xu, CR; Xu, SC; Yuan, YP; Zeng, XF; Zhang, N | 1 |
Chen, S; Qiu, Y; Rong, Y; Xu, Y; Yang, B | 1 |
Aloud, BM; Blewett, H; Duhamel, TA; Hiebert, B; Jahan, F; Kirby, C; Louis, XL; McCallum, J; Netticadan, T; Raj, P; Wigle, JT; Yu, L | 1 |
Hou, M; Liu, Y; Pin, L; Shang, L; Shun, M; Zhang, Y; Zhong, X; Zhu, S | 1 |
Akagi, S; Akazawa, K; Ito, H; Kimura, T; Kondo, M; Miura, D; Miyoshi, T; Nakamura, K; Ohno, Y; Saito, Y; Wada, J; Yoshida, M | 1 |
Bian, ZY; Dai, J; Deng, W; Tang, QZ; Yang, HX; Yuan, Y; Zhang, JY; Zhou, H; Zong, J | 1 |
Deng, J; Ding, W; Dong, M; Liu, J; Liu, Y; Xu, T; Yan, D | 1 |
Ding, W; Dong, M; Liao, Y; Liu, J; Liu, S; Liu, Y; Wang, R; Yan, D; Zhang, Y; Zheng, N | 1 |
Tan, Y; Yao, F; Zhang, N; Zhang, Q | 1 |
Hasegawa, Y; Kim-Mitsuyama, S; Koibuchi, N; Kusaka, H; Ogawa, H | 1 |
Li, F; Tang, Q; Wu, Q; Yang, Z; Yuan, Y; Zhang, N; Zhou, M; Zhu, J | 1 |
Bian, Z; Chen, C; Dai, J; Dong, X; Guo, H; Shu, C; Tang, Q; Zhang, DP; Zhang, Y; Zhou, H; Zong, J | 1 |
16 other study(ies) available for glucose, (beta-d)-isomer and Cardiac Hypertrophy
Article | Year |
---|---|
Phillyrin attenuates norepinephrine-induced cardiac hypertrophy and inflammatory response by suppressing p38/ERK1/2 MAPK and AKT/NF-kappaB pathways.
Topics: Animals; Cardiomegaly; Glucosides; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; NF-kappa B; Norepinephrine; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; Rats | 2022 |
Cardiac and renal function interactions in heart failure with reduced ejection fraction: A mathematical modeling analysis.
Topics: Benzhydryl Compounds; Cardiomegaly; Extracellular Fluid; Glucosides; Heart; Heart Failure; Hemodynamics; Humans; Kidney; Models, Cardiovascular; Myocytes, Cardiac; Sodium-Glucose Transporter 2 Inhibitors; Stroke Volume | 2020 |
Secoisolariciresinol diglucoside attenuates cardiac hypertrophy and oxidative stress in monocrotaline-induced right heart dysfunction.
Topics: Animals; Butylene Glycols; Cardiomegaly; Glucosides; Male; Monocrotaline; Oxidative Stress; Rats; Rats, Wistar; Ventricular Dysfunction, Right | 2017 |
Isosteviol prevents the prolongation of action potential in hypertrophied cardiomyoctyes by regulating transient outward potassium and L-type calcium channels.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Calcium Channels, L-Type; Cardiomegaly; Diterpenes, Kaurane; Glucosides; Myocardium; Myocytes, Cardiac; Potassium; Potassium Channels; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2017 |
Arctiin protects against cardiac hypertrophy through inhibiting MAPKs and AKT signaling pathways.
Topics: Administration, Oral; Animals; Arctium; Cardiomegaly; Cells, Cultured; Disease Models, Animal; Fibrosis; Furans; Glucosides; Male; MAP Kinase Signaling System; Mice, Inbred C57BL; Myocytes, Cardiac; Phytotherapy; Proto-Oncogene Proteins c-akt; Signal Transduction | 2017 |
Protection of Luteolin-7-O-glucoside against apoptosis induced by hypoxia/reoxygenation through the MAPK pathways in H9c2 cells.
Topics: Animals; Apoptosis; Cardiomegaly; Cardiotonic Agents; Cell Hypoxia; Cell Line; Flavones; Glucosides; MAP Kinase Signaling System; Myocardial Reperfusion Injury; Myocytes, Cardiac; Phosphorylation; Rats | 2018 |
Cyanidin 3-O-glucoside prevents the development of maladaptive cardiac hypertrophy and diastolic heart dysfunction in 20-week-old spontaneously hypertensive rats.
Topics: Animals; Anthocyanins; Blood Pressure; Cardiomegaly; Cell Survival; Cells, Cultured; Glucosides; Humans; Male; Myocytes, Cardiac; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley | 2018 |
Plantamajoside attenuates isoproterenol-induced cardiac hypertrophy associated with the HDAC2 and AKT/ GSK-3β signaling pathway.
Topics: Animals; Cardiomegaly; Catechols; Cell Line; Cell Survival; Disease Models, Animal; Glucosides; Glycogen Synthase Kinase 3 beta; Heart Ventricles; Histone Deacetylase 2; Isoproterenol; Male; Mice; Mice, Inbred BALB C; Myocardium; Myocytes, Cardiac; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction | 2019 |
Inhibitory Effects of Tofogliflozin on Cardiac Hypertrophy in Dahl Salt-Sensitive and Salt-Resistant Rats Fed a High-Fat Diet.
Topics: Animals; Benzhydryl Compounds; Blood Pressure; Cardiomegaly; Diet, High-Fat; Fibrosis; Glucosides; Interleukin-6; Ketones; Male; Models, Animal; Myocytes, Cardiac; Natriuretic Peptides; Rats; Rats, Inbred Dahl; Sodium-Glucose Transporter 2 Inhibitors | 2019 |
Paeoniflorin attenuates pressure overload-induced cardiac remodeling via inhibition of TGFβ/Smads and NF-κB pathways.
Topics: Animals; Apoptosis; Benzoates; Biomarkers; Bridged-Ring Compounds; Cardiomegaly; Fibrosis; Glucosides; Heart; Inflammation; Male; Mice; Mice, Inbred C57BL; Monoterpenes; Myocytes, Cardiac; NF-kappa B; Signal Transduction; Smad Proteins; Transforming Growth Factor beta; Ventricular Function, Left; Ventricular Remodeling | 2013 |
Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway.
Topics: Active Transport, Cell Nucleus; Animals; Atrial Natriuretic Factor; Calcineurin; Calcium; Calcium Signaling; Cardiomegaly; Cell Nucleus; Cells, Cultured; Glucosides; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocytes, Cardiac; Myosin Heavy Chains; NFATC Transcription Factors; Phenylephrine; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum; Stilbenes; Ventricular Remodeling | 2014 |
Polydatin prevents hypertrophy in phenylephrine induced neonatal mouse cardiomyocytes and pressure-overload mouse models.
Topics: Adrenergic alpha-1 Receptor Agonists; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cardiomegaly; Cardiotonic Agents; Cell Size; Cells, Cultured; Disease Models, Animal; Drugs, Chinese Herbal; Glucosides; Heart Failure; Heart Ventricles; Male; Mice, Inbred C57BL; Oxidative Stress; Phenylephrine; Rats; rho-Associated Kinases; Stilbenes; Ventricular Remodeling | 2015 |
Polydatin prevents angiotensin II-induced cardiac hypertrophy and myocardial superoxide generation.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Body Weight; Cardiomegaly; Cells, Cultured; Glucosides; Male; Myocardium; Myocytes, Cardiac; NADPH Oxidases; Organ Size; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resveratrol; RNA, Messenger; Signal Transduction; Stilbenes; Superoxides; Ventricular Myosins | 2015 |
Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome.
Topics: Adipocytes, White; Adiposity; Animals; Benzhydryl Compounds; Biomarkers; Cardiomegaly; Disease Models, Animal; Diuresis; Glucosides; Hemodynamics; Hypertrophy; Hypoglycemic Agents; Intra-Abdominal Fat; Male; Metabolic Syndrome; Oxidative Stress; Prediabetic State; Rats, Inbred SHR; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Time Factors; Water-Electrolyte Balance; Weight Gain | 2016 |
Syringin prevents cardiac hypertrophy induced by pressure overload through the attenuation of autophagy.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Autophagy; Cardiomegaly; Cardiotonic Agents; Cell Line; Glucosides; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Phenylpropionates; Pressure; Rats; Signal Transduction | 2017 |
Gastrodin protects against cardiac hypertrophy and fibrosis.
Topics: Animals; Benzyl Alcohols; Cardiomegaly; Collagen; Fibrosis; GATA4 Transcription Factor; Glucosides; Male; MAP Kinase Signaling System; Mice | 2012 |